HomeDTCFF • OTCMKTS
add
Defence Therapeutics Inc
Previous close
$0.44
Day range
$0.43 - $0.44
Year range
$0.31 - $1.00
Market cap
34.97M CAD
Avg Volume
9.44K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Seeking Alpha
1 hour ago
My Current View Of The S&P 500 Index: March 2026 Edition (Technical Analysis)
0.43%
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.37M | 132.59% |
Net income | -1.52M | -89.04% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.36M | -138.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 947.35K | 625.82% |
Total assets | 1.37M | 239.68% |
Total liabilities | 2.59M | -32.77% |
Total equity | -1.22M | — |
Shares outstanding | 57.37M | — |
Price to book | -22.00 | — |
Return on assets | -166.01% | — |
Return on capital | -375.97% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.52M | -89.04% |
Cash from operations | -1.40M | -109.47% |
Cash from investing | 6.06K | -67.41% |
Cash from financing | 27.14K | -95.82% |
Net change in cash | -1.37M | -202,799.56% |
Free cash flow | -918.35K | -137.12% |
About
Founded
2017
Headquarters
Website
